Based on our extensive expertise and know how we seek to ensure high quality, efficient and patient focused healthcare, locally as well as within an international environment. For this purpose Helios Health was founded in 2017.
Helios Health combines Helios Germany (Helios Kliniken) and Helios Spain (Quirónsalud in Spain) and bundles cooporations with other Fresenius business segments such as Fresenius Vamed and Fresenius Kabi.
We are constantly looking for further growth opportunities and aim to facilitate know how exchange between healthcare providers and systems worldwide.
Our focus is people. Here you get to know, what makes us unique. | Video: Helios
We focus on acute care and near acute care activities in a structural framework that we can develop and advance based on our expertise and experience. In addition, we seek to provide cross-sectoral integrated patient care connecting in inpatient and outpatient care in the best suitable way for our patients. This promotes coordinated treatment and care pathways, reduced length of hospital stays and faster recovery of our patients.
In line with our international growth strategy we are not interested in the acquisition of single / stand-alone hospitals but rather in the integration of hospital groups or medical center chains in order to create and develop healthcare platforms. We also cooperate with the other Fresenius business segments being active in healthcare in over 100 countries worldwide.
We usually aim for a sole shareholder position or to acquire a controlling stake to assume full responsibility for the operating business.
At our Fresenius Helios companies, we work continuously to preserve life, promote health and improve the quality of life of our patients.
Acting ethically is part of our corporate responsibility. This includes respecting human rights, protecting the environment and using resources efficiently. We are guided by international standards and applicable legislation.
We therefore anchor regulatory requirements (e.g. Supply Chain Due Diligence Act – SCDDA = LkSG) and social expectations in our human rights program, which applies to the Fresenius Helios Group as a whole, and fulfill our duty of care to respect human rights.
Helios participates in the Group-wide human rights program of the parent company Fresenius. Roles and responsibilities established for the human rights risk analysis define and implement adequate measures or further develop existing ones in order to prevent, eliminate or reduce potential negative impacts on rights holders through our business activities and in our supply chain.
As human rights due diligence is an ongoing task, we regularly review our measures and processes and adapt them where necessary.
Helios Health is also committed to respecting human rights in a human rights statement: The management of Helios Health GmbH has adopted the declaration of principles of its parent company, Fresenius Management SE, on respecting human rights in the Fresenius Group. Our Fresenius Helios human rights statement applies to the entire Fresenius Helios Group, including Quirónsalud and Helios Germany.
The statement, which was first developed in 2018 and has been continuously refined, is based on the United Nations (UN) and the fundamental principles of the International Labour Organization (ILO) and also meets the requirements of the Supply Chain Due Diligence Act (LkSG).
We update our statement every first quarter of a new year with new conclusions from our annual and ad hoc risk analyses, with a focus on human rights and environmental aspects.
Reports on possible human rights or other types of compliance violations can be reported around the clock, either anonymously or by name, via the Fresenius whistleblower system Human Rights | FSE (fresenius.com)
All companies that fall under the scope of the Supply Chain Due Diligence Act (SCDDA = Lieferkettensorgfaltspflichtengesetz (LkSG)) are obliged to regularly publish a report on the fulfillment of the due diligence obligations enshrined in the law.
The report on the fulfillment of the human rights and environmental due diligence obligations of Helios Health GmbH in accordance with the LkSG can be found below. This report includes information on the Quirónsalud Group in Spain and Latin America and the Helios Group in Germany.
The report contains information shared with the Federal Office for Economic Affairs and Export Control (BAFA). Questions and answers are taken from the BAFA online portal.
Alle Unternehmen, die unter den Anwendungsbereich des Lieferkettensorgfaltspflichtengesetzes (LkSG) fallen, sind verpflichtet, regelmäßig einen Bericht über die Erfüllung der im Gesetz verankerten Sorgfaltspflichten zu veröffentlichen.
Den Bericht über die Erfüllung der menschenrechtlichen und umweltbezogenen Sorgfaltspflichten gemäß LkSG der Helios Health GmbH finden Sie nachfolgend. Dieser Bericht umfasst Informationen zur Quirónsalud-Gruppe in Spanien und Lateinamerika sowie zur Helios-Gruppe in Deutschland.
Der Bericht beinhaltet die mit dem Bundesamt für Wirtschaft und Ausfuhrkontrolle (BAFA) geteilten Informationen. Fragen und Antworten sind aus dem BAFA-Onlineportal entnommen.
Kontakt
Helios Health GmbH
Else-Kröner-Str. 1
61352 Bad Homburg
Deutschland